Piergiorgio Donati
Chief Tech/Sci/R&D Officer bei AC IMMUNE SA
Vermögen: 72 582 $ am 31.03.2024
Profil
Piergiorgio Donati is currently the Chief Technical Operations Officer at AC Immune SA. Previously, he held the position of Head-Manufacturing & Project Management at AC Immune SA from 2011 to 2015.
He also served as the Head-Research & Development at Serono SA. From 2015 to 2018, he worked as the Head-CMC Program Development at Glenmark Pharmaceuticals Inc., USA. Prior to that, he was the Project Manager-Research & Development at Abiogen Pharma SpA from 2007 to 2011.
Mr. Donati completed his undergraduate degree at the Technical Institute of Jiangsu.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AC IMMUNE SA
0,02% | 01.03.2024 | 24 521 ( 0,02% ) | 72 582 $ | 31.03.2024 |
Aktive Positionen von Piergiorgio Donati
| Unternehmen | Position | Beginn |
|---|---|---|
| AC IMMUNE SA | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Piergiorgio Donati
| Unternehmen | Position | Ende |
|---|---|---|
Glenmark Pharmaceuticals Inc., USA
 Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Corporate Officer/Principal | 01.01.2018 |
| AC IMMUNE SA | Corporate Officer/Principal | 01.09.2015 |
Abiogen Pharma SpA
 Abiogen Pharma SpA Miscellaneous Commercial ServicesCommercial Services Abiogen Pharma SpA manufactures and develops pharmaceutical products. The firm offers therapeutic drugs in the anti-inflammatory and painkiller, respiratory, bone metabolism, and dermatology areas. The company was founded by Massimo di Martino in 1997 and is headquartered in Pisa, Italy. | Corporate Officer/Principal | 01.03.2011 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Piergiorgio Donati
| Technical Institute of Jiangsu | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Glenmark Pharmaceuticals Inc., USA
Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Health Technology |
Abiogen Pharma SpA
Abiogen Pharma SpA Miscellaneous Commercial ServicesCommercial Services Abiogen Pharma SpA manufactures and develops pharmaceutical products. The firm offers therapeutic drugs in the anti-inflammatory and painkiller, respiratory, bone metabolism, and dermatology areas. The company was founded by Massimo di Martino in 1997 and is headquartered in Pisa, Italy. | Commercial Services |
